← All candidates
No insider filings on record.
1 filing on record.
BDRXBiodexa Pharmaceuticals Plc
NasdaqCM · Healthcare · $1.34M
$1.12
-25.21% today
No insider filings on record.
Biodexa Pharmaceuticals Plc hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 8×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what BDRX ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.34M
Float
0.6M
58% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
No insider transactions on file for BDRX yet.
Context
Wall St
$10.17 avg target
+808.3% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 1 quarters beat
Q2 '26$0.00 act+$0.00
Coverage
European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingMT Newswires · 4d agoEuropean Equities Traded in the US as American Depositary Receipts Drop in Thursday TradingMT Newswires · 5d agoEuropean Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday TradingMT Newswires · 1w agoEuropean Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday TradingMT Newswires · 2w ago
The file stays open
1 filing on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice